Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ArthroCare makes Fitzgerald permanent head

This article was originally published in Clinica

Executive Summary

David Fitzgerald, who has been serving as interim president and CEO for minimally-invasive surgical technologies developer ArthroCare since February, has taken up the role on a permanent basis. Mr Fitzgerald joined ArthroCare's board of directors in 2003 – his career includes 25 years at Pfizer, of which the last 15 were spent as president and CEO of its Howmedica Orthopedics division. He took the helm of Austin, Texas-based ArthroCare after its previous president and CEO Michael Baker stepped down following an internal audit of the company which found evidence of improper business practices by its staff (, February 19 2009).






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts